Thymalfasin for Chronic Hepatitis B: Clinical Evidence Review
Thymalfasin (thymosin alpha-1) demonstrated durable sustained response rates in chronic hepatitis B with excellent tolerability, supporting its use as an immune-based HBV therapy alternative to interferon.
Quick Facts
What This Study Found
Thymalfasin achieved sustained HBV virological response with increasing durability over follow-up and minimal side effects, positioning it as a well-tolerated immune-based alternative for chronic hepatitis B treatment.
Key Numbers
How They Did This
review study on thymosin-alpha-1, infection.
Why This Research Matters
Relevant for thymosin-alpha-1, infection, immune-function, clinical-trials.
The Bigger Picture
Advances peptide therapeutics research.
What This Study Doesn't Tell Us
See abstract.
Questions This Raises
- ?Further research needed.
- ?Clinical translation to evaluate.
Trust & Context
- Key Stat:
- Key finding Thymalfasin achieved sustained HBV virological response with increasing durability over follow-up and minimal side effects, positioning it as a well-t
- Evidence Grade:
- moderate evidence.
- Study Age:
- Published in 2004.
- Original Title:
- Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.
- Published In:
- Journal of gastroenterology and hepatology, 19(12), S73-5 (2004)
- Authors:
- Liaw, Yun-Fan(2)
- Database ID:
- RPEP-00941
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What was studied?
Thymalfasin for Chronic Hepatitis B: Clinical Evidence Review
What was found?
Thymalfasin (thymosin alpha-1) demonstrated durable sustained response rates in chronic hepatitis B with excellent tolerability, supporting its use as an immune-based HBV therapy alternative to interferon.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-00941APA
Liaw, Yun-Fan. (2004). Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.. Journal of gastroenterology and hepatology, 19(12), S73-5.
MLA
Liaw, Yun-Fan. "Thymalfasin (thymosin-alpha 1) therapy in patients with chronic hepatitis B.." Journal of gastroenterology and hepatology, 2004.
RethinkPeptides
RethinkPeptides Research Database. "Thymalfasin (thymosin-alpha 1) therapy in patients with chro..." RPEP-00941. Retrieved from https://rethinkpeptides.com/research/liaw-2004-thymalfasin-thymosinalpha-1-therapy
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.